(Q69746690)

English

Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside

scientific article published on 01 January 1987

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3815728%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3815728%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

based on heuristic

inferred from title

author name string

H D Preisler

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3815728%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Y M Rustum

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3815728%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

N Azarnia

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3815728%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

R Priore

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3815728%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

publication date

1 January 1987

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3815728%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3815728%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3815728%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3815728%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

69-74

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3815728%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00296260

0 references

Metabolism and intracellular retention of 1-beta-D-arabinofuranosylcytosine as predictors of response of animal tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of patients with acute nonlymphocytic leukemia in remission.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between leukemic cell retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and response to therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uptake and phosphorylation of cytosine arabinoside by normal and leukemic human blood cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute myeloid leukaemia with a triple cytotoxic regime: dat

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of acute myelocytic leukemia in patients 30 years of age and younger

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69746690&oldid=1753450148"